Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Jones Financial Companies Lllp
Jones Financial Companies Lllp boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by ...
Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Zacks Research Issues Pessimistic Outlook for VRTX Earnings
Equities researchers at Zacks Research decreased their Q3 2026 earnings per share (EPS) estimates for shares of Vertex ...
Benzinga.com17d
Analyst Expectations For Vertex Pharmaceuticals's Future
Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through ...
pharmaphorum19d
Vertex's latest cystic fibrosis combination approved in US
Symdeko is approved in patients aged 12 or over who have two copies of the F508del mutation in the CFTR gene, who have at least one mutation that is responsive to the drug. Approval was based on ...
StockNews13d
3 Pharmaceutical Stocks With Blockbuster Drug Potential
The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...
Investing12d
Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Inc Aktie und aktueller Aktienkurs: Bleiben Sie über den aktuellen Aktienkurs von Vertex Pharmaceuticals Inc (VRTX) stets informiert - direkt auf dieser Seite. Behalten Sie ...